Laguna Pharmacueticals' Option/Warrant Round

Laguna Pharmacueticals raised a round of funding on June 12, 2014. Investors include Sante Ventures.

Laguna Pharmaceuticals, formerly known as ChanRx, is a biopharmaceutical company advancing vanoxerine for treatment of atrial fibrillation and atrial flutter.…

Articles about Laguna Pharmacueticals' Option/Warrant Round: